Are antibiotic doses right for High-Risk surgery patients?
NCT ID NCT07558681
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the usual dose of the antibiotic piperacillin/tazobactam is enough to prevent infections during major liver or pancreas surgery. Researchers will measure antibiotic levels in the blood of 60 adult patients during surgery. The goal is to see if current dosing works or needs to be adjusted for these high-risk procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
piperacillin/tazobactam (antibiotic)
What this could lead to
If successful, this could lead to better antibiotic dosing guidelines for liver and pancreas surgery patients, potentially reducing surgical infections.
What could go wrong
This is a small, early observational study (60 people) that only measures drug levels—it does not test whether infections are actually prevented. Results may not apply to all hospitals or patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBIOTIC PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU de Nancy
Vandœuvre-lès-Nancy, Lorraine, 54500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••